(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Heparan sulfate modification is required for lacrimal gland
development. (A-C) Total heparan sulfate identified by the 3G10
antibody (red) was ubiquitously expressed in lacrimal gland (arrow) and the
surrounding mesenchyme. HS, heparan sulfate. (D-F) Sulfated heparan
sulfate recognized by the 10E4 antibody (red) exhibited restricted expression,
with the strongest staining at the tip of Pax6-positive lacrimal gland bud
(arrow). (G-I) Ndst1 is expressed in the lacrimal gland bud as
marked by Pax6 staining (arrowhead). (J-L) Ndst1-/-
animals failed to develop lacrimal gland as shown by aceto-carmine staining
and GFP expression (arrow). p, posterior stalk; t, tip.